Formula & Concentration

Varicella Zoster Immune Globulin (Human)


Saol Therapeutics


VARIZIG is a Varicella Zoster Immune Globulin (Human) indicated for postexposure
prophylaxis in high risk individuals (1). High risk groups include:

  • immunocompromised children and adults,
  • newborns of mothers with varicella shortly before or after delivery,
  • premature infants,
  • infants less than one year of age,
  • adults without evidence of immunity,
  • pregnant women.

VARIZIG administration is intended to reduce the severity of varicella.

Product Options

Package Size NDC Presentation
≥125 IU 70504-0126-2 Vial

Shelf Life & Storage

Store VARIZIG at 2 to 8°C (36 to 46°F). Do not freeze. Do not use after expiration date.


Order Online

or call


Can't find what you are looking for?

Please call us and we would love to help.